Supplementary table III
Published: 27 September 2022| Version 1 | DOI: 10.17632/kfz4sb8sbt.1
Contributor:
Description
Overview of treatment discontinuation.
Files
Institutions
Universiteit van Amsterdam
Categories
Safety, Ethnicity, Race, Systemic Treatment, Atopic Dermatitis, Methotrexate, Skin Type